Fengmin Zhao
Anhui University of Science and Technology(CN)Northwest University(CN)Eastern Cooperative Oncology Group(US)Shanghai Medical Information Center(CN)ECOG-ACRIN Cancer Research Group(US)People's Hospital of Cangzhou(CN)Dana-Farber Cancer Institute(US)Dana-Farber/Harvard Cancer Center(US)Guizhou Institute of Plant Protection(CN)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Cancer survivorship and care, Advanced Breast Cancer Therapies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade(2017)358 cited
- → Prevalence and characteristics of moderate to severe fatigue: A multicenter study in cancer patients and survivors(2013)358 cited
- → The symptom burden of cancer: Evidence for a core set of cancer‐related and treatment‐related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study(2013)308 cited
- → Phase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic Melanoma(2012)220 cited
- → Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer(2015)220 cited
- → Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancer(2012)208 cited